4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-24-000071
President & CEO sold 30,000 shares at $47.87 ($1,436,100)
From the SEC's structured data for this filing
Trades in this filing
KAKKIS EMIL D · President & CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-12-29 | Sale : show line 1 in the form | −30,000 | $47.87 | $1,436,100 | 569,770 | D |
| Open-market sales · 30,000 sh · avg $47.87 · $1,436,100 | ||||||
Loading xslF345X05/doc4.xml…